Autolus Therapeutics plc (AUTL) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$75.4M

Net Income/Loss (FY2025)

-$287.5M

Total Assets (FY2025)

$589.1M

Total Equity (FY2025)

$178.1M

Cash Flows from Operating Activities (FY2025)

-$283.6M

Source: Autolus Therapeutics plc 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.